Sharry Kahlon1, Jenelle Pederson1, Sumit R Majumdar1, Sara Belga1, Darren Lau1, Miriam Fradette1, Debbie Boyko1, Jeffrey A Bakal1, Curtis Johnston1, Raj S Padwal1, Finlay A McAlister2. 1. Division of General Internal Medicine (Kahlon, Pederson, Majumdar, Belga, Lau, Padwal, McAlister); Patient Health Outcomes Research and Clinical Effectiveness Unit (Bakal, McAlister); Epidemiology Coordinating and Research (EPICORE) Centre (Fradette, Boyko, McAlister), University of Alberta; Department of Medicine (Johnston), Royal Alexandra Hospital, Edmonton, Alta. 2. Division of General Internal Medicine (Kahlon, Pederson, Majumdar, Belga, Lau, Padwal, McAlister); Patient Health Outcomes Research and Clinical Effectiveness Unit (Bakal, McAlister); Epidemiology Coordinating and Research (EPICORE) Centre (Fradette, Boyko, McAlister), University of Alberta; Department of Medicine (Johnston), Royal Alexandra Hospital, Edmonton, Alta. finlay.mcalister@ualberta.ca.
Abstract
BACKGROUND: Readmissions after hospital discharge are common and costly, but prediction models are poor at identifying patients at high risk of readmission. We evaluated the impact of frailty on readmission or death within 30 days after discharge from general internal medicine wards. METHODS: We prospectively enrolled patients discharged from 7 medical wards at 2 teaching hospitals in Edmonton. Frailty was defined by means of the previously validated Clinical Frailty Scale. The primary outcome was the composite of readmission or death within 30 days after discharge. RESULTS: Of the 495 patients included in the study, 162 (33%) met the definition of frailty: 91 (18%) had mild, 60 (12%) had moderate, and 11 (2%) had severe frailty. Frail patients were older, had more comorbidities, lower quality of life, and higher LACE scores at discharge than those who were not frail. The composite of 30-day readmission or death was higher among frail than among nonfrail patients (39 [24.1%] v. 46 [13.8%]). Although frailty added additional prognostic information to predictive models that included age, sex and LACE score, only moderate to severe frailty (31.0% event rate) was an independent risk factor for readmission or death (adjusted odds ratio 2.19, 95% confidence interval 1.12-4.24). INTERPRETATION: Frailty was common and associated with a substantially increased risk of early readmission or death after discharge from medical wards. The Clinical Frailty Scale could be useful in identifying high-risk patients being discharged from general internal medicine wards.
BACKGROUND: Readmissions after hospital discharge are common and costly, but prediction models are poor at identifying patients at high risk of readmission. We evaluated the impact of frailty on readmission or death within 30 days after discharge from general internal medicine wards. METHODS: We prospectively enrolled patients discharged from 7 medical wards at 2 teaching hospitals in Edmonton. Frailty was defined by means of the previously validated Clinical Frailty Scale. The primary outcome was the composite of readmission or death within 30 days after discharge. RESULTS: Of the 495 patients included in the study, 162 (33%) met the definition of frailty: 91 (18%) had mild, 60 (12%) had moderate, and 11 (2%) had severe frailty. Frail patients were older, had more comorbidities, lower quality of life, and higher LACE scores at discharge than those who were not frail. The composite of 30-day readmission or death was higher among frail than among nonfrail patients (39 [24.1%] v. 46 [13.8%]). Although frailty added additional prognostic information to predictive models that included age, sex and LACE score, only moderate to severe frailty (31.0% event rate) was an independent risk factor for readmission or death (adjusted odds ratio 2.19, 95% confidence interval 1.12-4.24). INTERPRETATION: Frailty was common and associated with a substantially increased risk of early readmission or death after discharge from medical wards. The Clinical Frailty Scale could be useful in identifying high-risk patients being discharged from general internal medicine wards.
Authors: Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson Journal: J Gerontol A Biol Sci Med Sci Date: 2004-03 Impact factor: 6.053
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Kumar Dharmarajan; Angela F Hsieh; Zhenqiu Lin; Héctor Bueno; Joseph S Ross; Leora I Horwitz; José Augusto Barreto-Filho; Nancy Kim; Susannah M Bernheim; Lisa G Suter; Elizabeth E Drye; Harlan M Krumholz Journal: JAMA Date: 2013-01-23 Impact factor: 56.272
Authors: Puneeta Tandon; Navdeep Tangri; Lesley Thomas; Laura Zenith; Tahira Shaikh; Michelle Carbonneau; Mang Ma; Robert J Bailey; Saumya Jayakumar; Kelly W Burak; Juan G Abraldes; Amanda Brisebois; Thomas Ferguson; Sumit R Majumdar Journal: Am J Gastroenterol Date: 2016-08-02 Impact factor: 10.864
Authors: Yibo Li; Jenelle L Pederson; Thomas A Churchill; Adrian S Wagg; Jayna M Holroyd-Leduc; Kannayiram Alagiakrishnan; Raj S Padwal; Rachel G Khadaroo Journal: CMAJ Date: 2018-02-20 Impact factor: 8.262
Authors: Karen E Joynt Maddox; Mat Reidhead; Jianhui Hu; Amy J H Kind; Alan M Zaslavsky; Elna M Nagasako; David R Nerenz Journal: Health Serv Res Date: 2019-04 Impact factor: 3.402